How should a 10½‑year‑old with iatrogenic thoracic duct injury from C5‑C6 anterior cervical discectomy and fusion presenting with acute chest pressure, dyspnea, facial and neck edema, pulsatile ear sounds, dysphagia, cough, cyanotic extremities, tachycardia, and new‑onset hypotension be managed?

Immediate Surgical Referral for Thoracic Duct Embolization or Ligation is Required

This 10½-year untreated iatrogenic thoracic duct injury from C5-C6 ACDF presenting with acute cardiorespiratory compromise, facial/neck edema, cyanotic extremities, and new hypotension represents a life-threatening emergency requiring immediate intervention—conservative management has clearly failed after a decade, and the patient now exhibits signs of superior vena cava syndrome, possible cardiac tamponade, and critical lymphatic obstruction that mandate urgent thoracic duct embolization (TDE) or surgical ligation.

Critical Clinical Context

The constellation of symptoms—chest pressure, dyspnea, global facial/head/neck swelling, pulsatile tinnitus, dysphagia, upper extremity cyanosis with weakness, tachycardia, and new hypotension—suggests massive chyle accumulation with secondary complications including:

• Superior vena cava obstruction from chronic lymphatic fluid accumulation
• Possible chylopericardium with cardiac tamponade (chest pressure, hypotension, tachycardia)
• Chronic chylothorax with respiratory compromise
• Severe nutritional depletion and immunosuppression from decade-long chyle loss

The immediate post-surgical onset confirms iatrogenic thoracic duct injury during the C5-C6 ACDF procedure 1.

Immediate Diagnostic Workup

Within hours, obtain:

• Chest X-ray to identify pleural effusion and mediastinal shift 1
• Echocardiography to assess for pericardial effusion and tamponade physiology 2
• CT chest with IV contrast to evaluate mediastinal structures, vascular compression, and fluid collections 3
• Thoracentesis with pleural fluid analysis: triglyceride level >110 mg/dL and pleural fluid-to-serum triglyceride ratio >1.0 confirms chylothorax 1
• If pericardial effusion present: pericardiocentesis with fluid triglyceride analysis (chylopericardium diagnosis) 2

Management Algorithm

Step 1: Immediate Stabilization (First 24 Hours)

• Hemodynamic support: IV fluid resuscitation for hypotension, but avoid aggressive fluid overload that increases central venous pressure 4
• Respiratory support: supplemental oxygen; prepare for possible intubation if respiratory distress worsens
• Urgent drainage:
  • Tube thoracostomy if significant chylothorax present 1
  • Pericardiocentesis if tamponade physiology confirmed 2
• NPO status with total parenteral nutrition (TPN) to immediately reduce chyle production 1
• Fluid and protein replacement to address decade-long nutritional depletion 1

Step 2: Definitive Intervention (Within 48-72 Hours)

After 10½ years of untreated injury, conservative management is futile. The ACR guidelines clearly state that invasive treatment is indicated when conservative therapy fails after 2 weeks, in high-output chylothorax, or when complications develop 1. This patient has exceeded all thresholds.

Primary recommendation: Thoracic duct embolization (TDE)

• 90% clinical resolution rate for traumatic thoracic duct leaks 1
• Minimally invasive compared to open surgery 5, 6
• Requires pre-procedural lymphangiography (pedal or intranodal) to identify the thoracic duct and leak site 1
• Type I TDE (direct embolization) preferred if leak site identified; Type II (needle disruption) if leak not visualized 1
• Minor complications in only 2-6% of cases 1

Alternative if TDE unavailable or fails: Surgical thoracic duct ligation

• Via thoracotomy or video-assisted thoracoscopic surgery (VATS) 1
• Success rates 50-70% but more invasive 1
• May require pleurodesis or pleurectomy if persistent leak 1

Step 3: Adjunctive Therapies

• Octreotide 100 mcg subcutaneously three times daily to reduce chyle production 2, 4, 7
  • ESC guidelines support this as Class IIb recommendation for chylopericardium 2
  • Continue for minimum 2 weeks 2
• Medium-chain triglyceride diet once oral intake resumed (MCTs absorbed directly into portal circulation, bypassing thoracic duct) 1, 4, 7

Step 4: Address Chylopericardium if Present

If pericardial fluid triglycerides confirm chylopericardium:

• Pericardiocentesis alone is seldom effective 2, 8
• Radical pericardiectomy plus thoracic duct treatment is optimal therapy 2, 8
• May require pericardio-peritoneal window if pericardiectomy not feasible 8

Critical Pitfalls to Avoid

1. Do not delay intervention for prolonged conservative trial: After 10½ years untreated, further delay risks death from malnutrition, immunosuppression, or acute cardiorespiratory collapse 1, 4, 9

2. Do not miss chylopericardium: The chest pressure, hypotension, and tachycardia mandate echocardiography—chylopericardium can cause tamponade and requires different surgical approach than isolated chylothorax 2

3. Avoid aggressive fluid resuscitation without drainage: Increased central venous pressure worsens lymphatic leak 4

4. Do not use anticoagulation: In iatrogenic injury setting, anticoagulation increases tamponade risk 2

5. Recognize this is NOT simple chylothorax: The facial/neck edema and pulsatile tinnitus suggest SVC syndrome from chronic mediastinal lymphatic obstruction—requires vascular imaging and possible additional intervention

Expected Outcomes

• With TDE: 90% clinical resolution for traumatic leaks, 72% with thoracic duct disruption technique 1
• Long-term complications (leg swelling, abdominal swelling, chronic diarrhea) occur in up to 14% but are preferable to untreated disease 1
• Untreated chylothorax mortality: up to 50% 4, 9

Multidisciplinary Team Required

• Interventional radiology for TDE 5, 6
• Cardiothoracic surgery for backup surgical ligation or pericardiectomy 1, 2
• Critical care for hemodynamic management
• Nutrition support for TPN and dietary management 1

The decade-long delay has created a complex, multi-compartment lymphatic catastrophe. Immediate imaging, drainage, and definitive thoracic duct intervention within 72 hours are essential to prevent mortality.